Explore a full list of faculty mentors, sorted by fellowship track.
Leadership
Kevin B. Stephenson, MD
Fellowship director
PI on five active clinical trials enrolling 11,000+ participants in maternal-child nutrition and perinatal mental health across Sierra Leone, Malawi, and Ghana.
Brian F. Gage, MD, MSc
Fellowship co-director
Developed the CHADS₂ score and led the GIFT trial of pharmacogenomic warfarin dosing (JAMA 2017), funded by the NIH and CMS. R01-funded (NHLBI) for ongoing research on machine learning refinement of pharmacogenomic warfarin dosing.
Molly McNairy, MD, MSc
Chief, Division of General Internal Medicine
International expert in HIV and cardiovascular diseases in settings of extreme poverty with extensive NIH funding for clinical research and research training and mentorship.
View faculty by track
Select a fellowship track below to meet the affiliated faculty.
| Affiliated Faculty | Division | Overview |
|---|---|---|
| Anubha Agarwal, MD, MSc | Cardiovascular | Polypill research contributed to placing polypills on the WHO Model List of Essential Medicines (Nature Medicine 2024). NHLBI K99/R00 supported a pilot hybrid RCT of a four-pillar heart failure intervention. |
| Philip J. Budge, MD, PhD | Infectious Diseases | CDC Epidemic Intelligence Service alumnus. Senior author on a 2025 Lancet Infectious Diseases RCT showing moxidectin plus albendazole superior to ivermectin for lymphatic filariasis microfilaria clearance in Côte d’Ivoire. |
| Victor G. Dávila-Román, MD, FACC, FASE | Cardiovascular | Directs the WashU Cardiovascular Imaging and Clinical Research Core Laboratory (CIRCL). Multi-site CVD imaging programs across LMIC. Cross-listed in clinical research. |
| Peter U. Fischer, PhD | Infectious Diseases | PI of the Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Project, an NIH-funded multi-country program advancing diagnostic, genomic, and clinical trial methods for global ID elimination. |
| Sumanth Gandra, MD, MPH | Infectious Diseases | Member of WHO Expert Committee on Selection and Use of Essential Medicines. PI on CDC-funded India studies on hospital-onset bacteremia and antimicrobial resistance. |
| Mark D. Huffman, MD, MPH | Cardiovascular | Leads the HTN Programme implementing WHO HEARTS hypertension management across 60 facilities in Nigeria, and the ENHANCE-CVH trial across 40 facilities in Abuja. |
| Juliet Iwelunmor, PhD | Infectious Diseases | Directs the Light Institute for Global Health and Transformation, with $20M+ in NIH funding. Leads multiple NIH programs on HIV prevention, D&I science, and global health equity. |
| Margaret E. Kruk, MD, MPH | General Internal Medicine | Chaired the Lancet Global Health Commission on High Quality Health Systems, which found 5.0M annual deaths in LMICs from poor-quality care. Directs the QuEST Network across 25+ countries, including the People’s Voice Survey instrument. |
| George B. Kyei, MD, MPhil, PhD | Infectious Diseases | PI of the HIV Cure Research Infrastructure Study (H-CRIS), a bi-institutional program operating dual labs at WashU and the University of Ghana Medical Centre. EDCTP Senior Fellowship awardee; identified novel HIV latency reversal mechanisms. |
| Zainab Mahmoud, MD, MSc | Cardiovascular | Research on racial disparities in maternal cardiovascular outcomes and global maternal cardiovascular health. NHLBI K23 for maternal cardiovascular outcomes in Nigeria. |
| Caline Mattar, MD | Infectious Diseases | Chair of the Expert Advisory Group at the Global AMR R&D Hub, a 15-country consortium with Gates and Wellcome support based in Germany. IDSA Fellow (2022). AMR and infection prevention in LMIC. |
| Proscovia Nabunya, PhD, MSW | WashU Bursky Public Health | Directs the International Center for Child Health and Development (ICHAD)’s Uganda-based applied-intervention portfolio, combining adolescent mental health, HIV stigma, and family economic empowerment. |
| Thomas A. Odeny, MD, MPH, PhD | Oncology | Leads the WashU global-oncology initiative, including a 5-year NCI-funded program ($2.7M) to improve Kaposi sarcoma treatment in Kenya. Global oncology and Kaposi sarcoma clinical trials. |
| Affiliated Faculty | Division | Overview |
|---|---|---|
| Michael J. Durkin, MD, MPH | Infectious Diseases | Antimicrobial stewardship and outpatient prescribing research combining administrative-data analytics, qualitative methods, and stewardship implementation across BJH and the BJC HealthCare system. Section chief of ID at John Cochran VA Medical Center. |
| Elvin H. Geng, MD, MPH | Infectious Diseases | ADAPT-R trial (NEJM Evidence, 2023). Co-Editor-in-Chief, Implementation Science Communications. 19 mentees with NIH K-series or career development awards. D&I science across HIV care engagement and adaptive trials. |
| James G. Krings, MD, MSCI | Pulmonary & Critical Care Medicine | Implementation science for asthma and COPD, bridging evidence-based guidelines and real-world inhaler adherence. NIH and American Lung Association funded. Completed the Mentored Training in Implementation Science (MTIS) program. |
| Aaloke Mody, MD | Infectious Diseases | Applies implementation science and advanced epidemiologic methods (natural experiments, causal inference on real-world data) to optimize HIV care in Zambia and the U.S. Co-I on a $4.5M Gates Foundation portfolio. |
| Byron J. Powell, PhD | Brown School | Lead author of the Expert Recommendations for Implementing Change (ERIC) compilation, the most-cited taxonomy in implementation science. Mechanisms research and implementation strategy design. |
| Affiliated Faculty | Division | Overview |
|---|---|---|
| Alison L. Antes, PhD | General Internal Medicine | Director of the MSCI degree program and director of education at the Bioethics Research Center. PI on the $2.1M NIH-funded COMPASS program developing leadership and management skills in early-career biomedical researchers. |
| Lauren L. Baker, PhD | General Internal Medicine | Applies social science methods to ethical, social, and policy dimensions of medicine and public health, including consent policy for youth in foster care and religious influences on attitudes toward genetic testing. |
| Anne Mobley Butler, PhD, MS | Infectious Diseases | Pharmacoepidemiologist specializing in non-experimental study designs, comparative effectiveness, and causal-inference methods applied to antibiotic and vaccine utilization in real-world data. |
| Yin Cao, ScD, MPH | Public Health Sciences | Lead of the Cancer Grand Challenges PROSPECT consortium (~$25M, 5 years), an international transdisciplinary study of early-onset colorectal cancer combining epidemiology, lab science, and clinical research. |
| James M. DuBois, DSc, PhD | General Internal Medicine | Externally funded portfolio exceeds $15M. Founded the Professionalism and Integrity in Research (PI) Program and co-founded the Association for Empirical Bioethics. Research ethics, informed consent, and mixed methods. |
| Bradley A. Evanoff, MD, MPH | General Internal Medicine | Long-running cohort studies of work-related injury epidemiology and prevention: carpal tunnel syndrome, fall prevention in construction, and participatory ergonomics across multiple industries. |
| Alexander O. Everhart, PhD | General Internal Medicine | Uses health economics to study how regulatory decisions shape the development, safety, and adoption of medical devices and pharmaceuticals, including FDA adverse event reporting and prescribing behavior after safety communications. |
| Kenton J. Johnston, PhD, MPH | General Internal Medicine | Health Affairs (2019) research showed access-to-care factors account for 89% of the rural-urban disparity in preventable hospitalizations among Medicare beneficiaries, with specialist access a major driver. Medicare and Medicaid policy. |
| Karen E. Joynt Maddox, MD, MPH | Cardiovascular | R01-funded (NIA). Former Senior Advisor, HHS Office of Health Policy during ACA implementation. Lead author of an AHA Scientific Statement forecasting CV disease burden in the U.S. |
| Albert M. Lai, PhD, FACMI, FAMIA | General Internal Medicine | Natural language processing and large language models for clinical trial prescreening and phenotype extraction. NIH-funded biomedical informatics research with focus on EHR-based feasibility. |
| Sunny C. Lin, PhD, MS | General Internal Medicine | Launched the Age-Friendly Health Systems Research Network. Studies Medicare value-based purchasing effects on vulnerable populations, nursing home quality disparities, and health IT adoption in aging services. |
| Tristan J. McIntosh, PhD | General Internal Medicine | PI on an NIH/NIMH R01 studying ethical issues in neurotechnology academia-industry partnerships. Co-directs COMPASS, a $2.1M NIH-funded leadership training program for early-career biomedical researchers. |
| Jessica Mozersky, PhD | General Internal Medicine | Co-PI on a $3.4M NIA R01 (WeSHARE) examining how to return Alzheimer’s disease risk results to healthy research participants. Co-directs the Responsible Conduct of Research program. |
| Philip R.O. Payne, PhD, FACMI, FAMIA | General Internal Medicine | Founding director of I2DB and inaugural Chief Health AI Officer of the joint WashU Medicine–BJC Center for Health AI. Health AI and clinical research informatics across translation pathways. |
| Rachel M. Presti, MD, PhD | Infectious Diseases | One of 25 initial enrolling sites for ACTIV-2. NIH AIDS Clinical Trials Unit PI. Co-director of the Center for Vaccines and Immunity to Microbial Pathogens. HIV, vaccines, and translational clinical trials. |
| Adam B. Wilcox, PhD, FACMI | General Internal Medicine | Elected Fellow of the American College of Medical Informatics. Previously chief analytics officer at UW Medicine and director of medical informatics. Learning health systems and EHR data science. |
| Po-Yin Yen, PhD, RN, FACMI, FAMIA, FAAN | General Internal Medicine | Fellow of AMIA, the American College of Medical Informatics, and the American Academy of Nursing. Research spans EHR documentation, nursing informatics, and health IT usability. |
| Affiliated Faculty | Division | Overview |
|---|---|---|
| Rachel H. Bardowell, MD, FACP | General Internal Medicine | Associate vice chair of inpatient medicine in the Department of Medicine’s Office of the Vice Chair for Patient Safety and Quality Improvement. Oversees quality of care across inpatient medicine services at Barnes-Jewish Hospital. |
| Thomas Ciesielski, MD | General Internal Medicine | Joint Commission Presidential Fellow for Healthcare Quality and Safety. Former vice chair of inpatient safety and quality for the Department of Medicine. Associate program director in the IM residency and inpatient teaching attending. Research focuses on medication safety, patient progression, and inpatient operations. |
| Safa Farrag, MD | General Internal Medicine | Leads Section of Hospital Medicine’s Quality Improvement and Patient Safety (QIPS) Committee, the operational home for inpatient safety initiatives across Barnes-Jewish Hospital. Mentors fellows and trainees on QI project design, safety event analysis, and committee-level implementation. |
| Kathryn (Katey) Filson, MD | General Internal Medicine | Co-director of patient care operations in Hospital Medicine. Chair of the section’s Compensation Committee. Focus on inpatient throughput, staffing models, and operations design at Barnes-Jewish Hospital. |
| Michael Y. Lin, MD, SFHM | General Internal Medicine | Section Chief of Hospital Medicine and medical director of the BJC HealthCare system transfer center. Senior Fellow of Hospital Medicine; national leadership roles within the Society of Hospital Medicine. |
| Patricia Litkowski, MD | General Internal Medicine | Medical director of patient experience at Barnes-Jewish Hospital and director of hospitalist services for Inpatient Medical Oncology. Member of the Hospital Medicine Interim Leadership Transition Team. Focus on patient experience, service-line operations, and transitions of care. |
| Peter McDonnell, MD | General Internal Medicine | Director of the Primary Care Internal Medicine Residency Program and assistant manager of the Primary Care Medicine Clinic. Research and teaching on ambulatory quality improvement, panel management, and resident education. |
| Robert Young, MD, MS | General Internal Medicine | Delirium care models, post-acute care transitions, and interdisciplinary teamwork for vulnerable older inpatients. Former medical director of an Acute Care for Elders co-management service. WashU Big Ideas Competition winner for Machine Learning Assisted Diagnosis of Delirium (ML-ADD) project. |
Ready to apply?
Applications are reviewed on a rolling basis. Reach out to fellowship director Kevin Stephenson, MD (k.stephenson@wustl.edu) before you apply. Most successful applicants have a mentor identified in advance.